Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Targeting Sirna in Colorectal Cancer Therapy: Nanotechnology Comes Into View Publisher Pubmed



Aghamiri S1 ; Jafarpour A2 ; Malekshahi ZV3 ; Mahmoudi Gomari M3 ; Negahdari B3
Authors

Source: Journal of Cellular Physiology Published:2019


Abstract

Colorectal cancer (CRC) is known as one of the most important causes of death and mortality worldwide. Although several efforts have been made for finding new therapies, no achievements have been made in this area. Multidrug resistance (MDR) mechanisms are one of the key factors that could lead to the failure of chemotherapy. Moreover, it has been shown that various chemotherapy drugs are associated with several side effects. Hence, it seems that finding new drugs or new therapeutic platforms is required. Among different therapeutic approaches, utilization of nanoparticles (NPs) for targeting a variety of molecules such as siRNAs are associated with good results for the treatment of CRC. Targeting siRNA-mediated NPs could turn off the effects of oncogenes and MDR-related genes. In the current study, we summarized various siRNAs targeted by NPs which could be used for the treatment of CRC. Moreover, we highlighted other routes such as liposome for targeting siRNAs in CRC therapy. © 2019 Wiley Periodicals, Inc.
Related Docs
View other Related Docs
1. Nanoparticle-Sirna: A Potential Strategy for Ovarian Cancer Therapy?, Nanomedicine (2019)
2. Recent Advances in Sirna Delivery Systems for Prostate Cancer Therapy, Current Pharmaceutical Biotechnology (2022)
3. Co-Delivery of Gemcitabine Prodrug Along With Anti Nf-Κb Sirna by Tri-Layer Micelles Can Increase Cytotoxicity, Uptake and Accumulation of the System in the Cancers, Materials Science and Engineering C (2020)
Experts (# of related papers)
View all Related Experts
Fatemeh Atyabi (4)
Fatameh Mottaghitalab (2)
Other Related Docs
4. Nonviral Sirna Delivery Systems for Pancreatic Cancer Therapy, Biotechnology and Bioengineering (2021)
5. Combination Therapy of Macromolecules and Small Molecules: Approaches, Advantages, and Limitations, Nanostructures for Cancer Therapy (2017)
6. Nano-Particles’ Benefits for Colon Cancer Effective Therapy: A Review of Recent Advancements and Clinical Trials, International Journal of Polymeric Materials and Polymeric Biomaterials (2024)
7. Nano-Scale Delivery Systems for Sirna Delivery in Cancer Therapy: New Era of Gene Therapy Empowered by Nanotechnology, Environmental Research (2023)
8. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
9. Stimuli-Responsive Mesoporous Silica Nps As Non-Viral Dual Sirna/Chemotherapy Carriers for Triple Negative Breast Cancer, Molecular Therapy Nucleic Acids (2017)
10. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and Igf-1R Sirna to Skbr3 Metastatic Breast Cancer Cells, Iranian Biomedical Journal (2019)
11. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
12. Inhibiting Influenza Virus Replication and Inducing Protection Against Lethal Influenza Virus Challenge Through Chitosan Nanoparticles Loaded by Sirna, Drug Delivery and Translational Research (2018)
13. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced Sirna Delivery and Silencing, International Journal of Molecular Sciences (2021)
14. Nanotechnological Approaches in Prostate Cancer Therapy: Integration of Engineering and Biology, Nano Today (2022)
15. Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects, Biomedicine and Pharmacotherapy (2022)
16. Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using Bi-Specific Antibodies and Therapeutic Vaccines, Biological Procedures Online (2021)
17. Sirna Nanotherapeutics: A Promising Strategy for Anti-Hbv Therapy, IET Nanobiotechnology (2019)
18. Antibody-Drug Therapeutic Conjugates: Potential of Antibody-Sirnas in Cancer Therapy, Journal of Cellular Physiology (2019)
19. Functionalized Liposomes As a Potential Drug Delivery Systems for Colon Cancer Treatment: A Systematic Review, International Journal of Biological Macromolecules (2024)
20. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)